Sonia Gandhi – Congress President:
I pay my homage to the farmers who have lost their lives & pray God gives their families strength in this time of grief.
Neither rain, nor cold. Neither lathis, nor water cannons.
Nothing can deter our farmers from fighting for their rights and as we have always done, today also, we stand with them.
The Modi govt should remember that democracy means protecting the interests of the people, the labour & the farmers.
The govt should immediately withdraw all 3 black laws & end the agitation.
This is true Rajdharma & a fitting tribute to the late farmers
Dr Harsh Vardhan – Union Health Minister:
For those spreading rumours let it be known that EUA for COVAXIN is differently conditional – in clinical trial mode
EUA for COVAXIN is different from COVISHIELD because its use will be in clinical trial mode.
All COVAXIN recipients to be tracked, monitored as if they’re in trial
COVAXIN approval is ‘Monitored Approval’ with strict follow-up & rolling review
This approval ensures India has an additional vaccine shield in its arsenal especially against potential mutant strains in a dynamic pandemic situation – A strategic decision for our vaccine security
N Chandrababu Naidu – Former Chief Minister, Andhra Pradesh:
I offer my thanks and gratitude to scientists and teams at Serum Institute and Bharat Biotech for all their hard work and commitment in bringing us a vaccine for COVID-19.
Congratulations on the DCGI approval and keep up the good work. We’re proud of you!
I also thank all the brave volunteers who participated in the trials, and the front-line health care workers who’ve been fighting the COVID-19 battle at the frontline.
We’re in awe of your efforts.
Piyush Goyal – Union Minister:
Kempegowda International Airport Halt Railway Station in Bengaluru, Karnataka is all set to serve travelers from 4th January.
This will go a long way in enhancing last-mile connectivity to Bengaluru airport, benefit lakhs of people and reduce the traffic congestion drastically.
The Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) met on 1st and 2nd January, 2021 and made recommendations in respect of proposal for Restricted Emergency Approval of COVID-19 virus vaccine of M/s Serum Institute of India and M/s Bharat Biotech as well as Phase III clinical trial of M/s Cadila Healthcare Ltd.
The Subject Expert Committee consists of domain knowledge experts from the fields of pulmonology, immunology, microbiology, pharmacology, paediatrics, internal medicine, etc.
M/s Serum Institute of India, Pune has presented a Recombinant Chimpanzee Adenovirus vector vaccine (Covishield) encoding the SARS-CoV-2 Spike (S) glycoprotein with technology transfer from AstraZeneca/Oxford University.
The firm submitted safety, immunogenicity and efficacy data generated on 23,745 participants aged ≥ 18 years or older from overseas clinical studies.
The overall vaccine efficacy was found to be 70.42%.
Further, M/s Serum was granted permission to conduct Phase-II/III clinical trial on 1600 participants within the country.
The firm also submitted the interim safety and immunogenicity data generated from this trial and the data was found comparable with the data from the overseas clinical studies.
After detailed deliberations Subject Expert Committee has recommended for the grant of permission for restricted use in emergency situation subject to certain regulatory conditions.
The clinical trial ongoing within the country by the firm will continue.
M/s Bharat Biotech has developed a Whole Virion Inactivated Corona Virus Vaccine (Covaxin) in collaboration with ICMR and NIV (Pune), from where they received the virus seed strains.
This vaccine is developed on Vero cell platform, which has well established track record of safety and efficacy in the country & globally.
The firm has generated safety and immunogenicity data in various animal species such as mice, rats, rabbits, Syrian hamster, and also conducted challenge studies on non-human primates (Rhesus macaques) and hamsters.
All these data has been shared by the firm with CDSCO.
Phase I and Phase II clinical trials were conducted in approx. 800 subjects and the results have demonstrated that the vaccine is safe and provides a robust immune response.
The Phase III efficacy trial was initiated in India in 25,800 volunteers and till date, ~22,500 participants have been vaccinated across the country and the vaccine has been found to be safe as per the data available till date.
The Subject Expert Committee (SEC) has reviewed the data on safety and immunogenicity of the vaccine and recommended for grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, to have more options for vaccinations, especially in case of infection by mutant strains.
The clinical trial ongoing within the country by the firm will continue.
M/s Cadila Healthcare Ltd., has developed a Novel Corona Virus-2019-nCov-Vaccine using DNA platform technology.
The firm initiated Phase-I/II clinical trial in India in more than 1000 participants which is ongoing.
The interim data suggests that the vaccine is safe and immunogenic with three doses when administered intradermally.
Accordingly, firm has sought permission to conduct Phase-III clinical trial in 26000 Indian participants, which has been recommended by the Subject Expert Committee.
M/s Serum and M/s Bharat Biotech vaccines have to be administered in two doses. All the three vaccines have to be stored at 2-8° C.
After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to M/s Cadila Healthcare for conduct of the Phase III clinical trial.
JP Nadda – National President, BJP:
Time and again we have seen whenever India achieves something commendable – that will further public good – the Congress comes up with wild theories to oppose and ridicule the accomplishments.
The more they oppose, the more they are exposed. Latest example is the Covid vaccines.
Congress and the Opposition is not proud of anything Indian.
They should introspect about how their lies on the COVID-19 vaccine will be used by vested interest groups for their own agendas.
People of India have been rejecting such politics and will keep doing so in the future.
Within a year of the COVID-19 pandemic coming to India, our scientists and innovators have worked hard for a vaccine to cure this pandemic.
While the entire nation is happy about this, the Opposition led Congress is filled with anger, ridicule and disdain.
To further their own failed politics and nefarious agendas, Congress and other Opposition leaders are trying to cause panic in the minds of the people.
I urge them to do politics on other issues, they should avoid playing with people’s precious lives and hard earned livelihoods.
Rahul Gandhi – MP, Former Congress President:
The Modi government, which is not providing legal guarantee of MSP to the farmers, is giving fixed price to its industrialist partners to run their godowns.
Government Mandis are either closed or food grains are not being purchased.
Why lack of attention to farmers and sympathy to suit-boot friends?
Shashi Tharoor – MP, Congress leader :
A college professor in Kerala sent me this evidence of the financial worth of her educational qualifications:
while we all applaud that sweepers are paid well,
studying long & hard for the higher degrees required by an Assistant Professor earns her a lower salary!
Sitaram Yechury – General Secretary, CPIM:
The announcement about the two vaccine candidates should be accompanied by full disclosure of the minutes of the meetings, information about all the trials and results in order to build confidence in the people.
This has been done globally. Our government should do so too.
Any attempt to short-circuit the regulatory process for political gains will damage the good reputation built by Indian pharma over the years.
India has a proud record of safe and scientifically sound mass vaccination programmes.
This must be adhered to. Our people are eagerly waiting for relief from the ravages of the pandemic and the vaccine.
Amitabh Kant – CEO, NITI Aayog:
Kutch Nahi Dekha To Kuch Nahi Dekha !
( If you have not seen Kutch you have seen nothing ).
N Biren Singh – Chief Minister, Manipur:
Visited my beloved Guru, Oja Huidrom Raghumani to check up on his health.
Oja who hasn’t been keeping well lately was the Founding President of Neroca Football Cup.
His guidance & encouragement helped me profoundly during my early football career.
I pray for his good health & long life.
Manish Tewari – MP, Former Union Minister:
Langar with farmers at Kisan Dharna.
Langar is organised by the Sant’s of Qila Anandgarh ( Sri Anandpur Sahib )
Amazing Energy the Tractor Trolley’s stretch for 16 KM’s towards Sonepat from the Dias.
They are not going home anytime soon
Rahul Gandhi, Congress :
The country is facing a tragedy situation like Champaran once again.
Earlier it was the British company and now it is the Modi-friends company .
But every farmer-worker of the farmers movement is a Satyagrahi who will continue to fight for his right.